A synthetic peptide for use as a blocking control in assays to test for specificity of SSX6 antibody, Alternative Names: SSX6 control peptide, SSX6 antibody Blocking Peptide, Anti-SSX6 Blocking Peptide, synovial sarcoma, X breakpoint 6 Blocking Peptide, dJ54B20.1 Blocking Peptide, SSX6, SSX-6, SSX 6, SSX-6 Blocking Peptide, SSX 6 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
SSX6
(Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6))
Synonyme
SSXP2 Peptide, dJ54B20.1 Peptide, psiSSX2 Peptide, SSX family member 6, pseudogene Peptide, SSX6 Peptide
Hintergrund
SSX6 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy.